反応 #1069757
ord-6476f3cbeb6643959e1a404384a9d32c
反応条件
後処理
- 1その他Two granules are prepared
- 2その他the granules obtained
- 3その他are then dried
- 4workup.ADDITIONThe other components, magnesium stearate, Aerosile® 200 and monosodium carbonate are then dry-added
- 5workup.ADDITIONmixed
- 6workup.ADDITIONFor granule 2, tiapride hydrochloride, Methocel® and Avicel® are dry-mixed
- 7その他the granules obtained
- 8その他are then dried
- 9workup.ADDITIONMagnesium stearate and Aerosile® are dry-added
- 10workup.ADDITIONmixed
- 11その他3-layer tablets are prepared
- 12workup.ADDITIONcontaining 250 mg of granule 1 in the first outer layer, 280 mg of granule 2 in the inner layer, which
実験手順
Two granules are prepared. For granule 1, Methocel® K100M, Avicel® PH102 and tartaric acid are dry-mixed and then granulated with water in a granulating blender and the granules obtained are then dried. The other components, magnesium stearate, Aerosile® 200 and monosodium carbonate are then dry-added and mixed. For granule 2, tiapride hydrochloride, Methocel® and Avicel® are dry-mixed and are then granulated with water in a granulating blender and the granules obtained are then dried. Magnesium stearate and Aerosile® are dry-added and mixed. 3-layer tablets are prepared, containing 250 mg of granule 1 in the first outer layer, 280 mg of granule 2 in the inner layer, which contains 100 mg of base tiapride in hydrochloride form, and 200 mg of granule 1 in the second outer layer.